Reproductive health drugs
Executive Summary
FDA's Advisory Committee for Reproductive Health Drugs will discuss the draft guidances "Evaluation of Human Pregnancy Outcome Data" and "Establishing Pregnancy Registries Data" on Oct. 18 beginning at 9 a.m. at the Holiday Inn in Gaithersburg, MdYou may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
Shire Hopes To Sow Future Deals With $50M Venture Fund
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: